Dunne Michael W. 4/A
4/A · Iterum Therapeutics plc · Filed Jun 5, 2023
Insider Transaction Report
Form 4/AAmended
Dunne Michael W.
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2023-04-01+1,299→ 37,635 total
Footnotes (2)
- [F1]Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
- [F2]This amendment is being filed solely to correct an error in the Amount of Securities Beneficially Owned Following Reported Transaction in the original Form 4, as filed on April 3, 2023. The Amount of Securities Beneficially Owned Following Reported Transaction on April 1, 2023, which were reported as 37,636, should have been reported as 37,635.